Walgreens Boots Alliance
About: Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
Employees: 312,000
0
Funds holding %
of 7,139 funds
0
Analysts bullish %
of 4 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
25% more funds holding in top 10
Funds holding in top 10: 4 [Q3] → 5 (+1) [Q4]
19% more call options, than puts
Call options by funds: $318M | Put options by funds: $268M
7% more capital invested
Capital invested by funds: $4.62B [Q3] → $4.96B (+$340M) [Q4]
2.08% more ownership
Funds ownership: 59.46% [Q3] → 61.54% (+2.08%) [Q4]
5% more first-time investments, than exits
New positions opened: 134 | Existing positions closed: 128
10% less repeat investments, than reductions
Existing positions increased: 271 | Existing positions reduced: 301
3% less funds holding
Funds holding: 867 [Q3] → 837 (-30) [Q4]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$8.50
16%
downside
Avg. target
$11.13
9%
upside
High target
$12
18%
upside
4 analyst ratings
0 positive
0%
3 neutral
75%
1 negative
25%
Truist Securities David Macdonald 59% 1-year accuracy 57 / 96 met price target | 18%upside $12 | Hold Maintained | 31 Jan 2025 |
RBC Capital Ben Hendrix 36% 1-year accuracy 24 / 67 met price target | 18%upside $12 | Sector Perform Maintained | 15 Jan 2025 |
Evercore ISI Group Elizabeth Anderson 51% 1-year accuracy 18 / 35 met price target | 18%upside $12 | In-Line Maintained | 13 Jan 2025 |
B of A Securities Allen Lutz 86% 1-year accuracy 12 / 14 met price target | 16%downside $8.50 | Underperform Maintained | 13 Jan 2025 |
Financial journalist opinion
Based on 277 articles about WBA published over the past 30 days
Neutral
Accesswire
15 hours ago
Levi & Korsinsky Reminds Walgreens Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 31, 2025 - WBA
NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your Walgreens Boots Alliance, Inc. (NASDAQ:WBA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/walgreens-boots-alliance-inc-lawsuit-submission-form-2?prid=131410&wire=1 or contact Joseph E. Levi, Esq.
Neutral
GlobeNewsWire
15 hours ago
WBA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Walgreens Boots Alliance, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Walgreens Boots Alliance, Inc. (“Walgreens” or “the Company”) (NASDAQ: WBA) and certain of its officers.
Neutral
GlobeNewsWire
18 hours ago
Shareholders of Walgreens Boots Alliance, Inc. Should Contact Levi & Korsinsky Before March 31, 2025 to Discuss Your Rights – WBA
NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Walgreens Boots Alliance, Inc. ("Walgreens" or the "Company") (NASDAQ: WBA) of a class action securities lawsuit.
Neutral
Accesswire
20 hours ago
Walgreens Boots Alliance, Inc. Class Action: Levi & Korsinsky Reminds Walgreens Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 31, 2025 - WBA
NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your Walgreens Boots Alliance, Inc. (NASDAQ:WBA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/walgreens-boots-alliance-inc-lawsuit-submission-form-2?prid=131351&wire=1 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
20 hours ago
A Lawsuit Has Been Filed Against Walgreens Boots Alliance, Inc. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESS Newswire / February 21, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Walgreens Boots Alliance, Inc. ("Walgreens" or "the Company") (NASDAQ:WBA) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between April 2, 2020 and January 16, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before March 31, 2025.
Neutral
Accesswire
21 hours ago
March 31, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against WBA
NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your Walgreens Boots Alliance, Inc. (NASDAQ:WBA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/walgreens-boots-alliance-inc-lawsuit-submission-form-2?prid=131281&wire=1 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
21 hours ago
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Walgreens Boots Alliance, Inc. and Certain Officers - WBA
NEW YORK, NY / ACCESS Newswire / February 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Walgreens Boots Alliance, Inc. ("Walgreens" or the "Company") (NASDAQ:WBA) and certain officers. The class action, filed in the United States District Court for the Northern District of Illinois, and docketed under 25-cv-01058, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Walgreens common stock between April 2, 2020 and January 16, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
Neutral
Accesswire
1 day ago
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 31, 2025 in Walgreens Lawsuit - WBA
NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your Walgreens Boots Alliance, Inc. (NASDAQ:WBA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/walgreens-boots-alliance-inc-lawsuit-submission-form-2?prid=131158&wire=1 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
1 day ago
WBA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Walgreens Boots Alliance, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, NY / ACCESS Newswire / February 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Walgreens Boots Alliance, Inc. ("Walgreens" or "the Company") (NASDAQ:WBA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Walgreens securities between April 2, 2020 and January 16, 2025, both dates inclusive (the "Class Period").
Positive
Seeking Alpha
1 day ago
Why Dividends Matter, Even The Little Ones
Dividends provide a reliable income stream, especially during tough economic times, alleviating financial pressure without the need to sell shares. Persistent inflation makes dividend income increasingly valuable, as it offers stability when market returns are volatile or negative. Investing in well-established, high-yield dividend companies with strong cash flows can ensure a steady income and reduce financial stress.
Charts implemented using Lightweight Charts™